Rachel Thomson
Overview
Explore the profile of Rachel Thomson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Webb E, Holland A, Chang A, Middleton P, Thomson R, Wong C, et al.
Pediatr Pulmonol
. 2024 Nov;
60(1):e27370.
PMID: 39503186
Background: Regular airway clearance techniques (ACTs) and exercise are recommended for children with bronchiectasis, but current clinical practice and their predictors are unknown. Objective: We aimed to describe current use...
2.
Shojaie A, Al Khleifat A, Garrahy S, Habash-Bailey H, Thomson R, Opie-Martin S, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Sep;
25(7-8):702-707.
PMID: 39218010
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the gradual death of motor neurons in the brain and spinal cord, leading to fatal paralysis. Socioeconomic status (SES) is...
3.
Huang C, Weerasekara A, Lu J, Carter R, Weynberg K, Thomson R, et al.
Water Res X
. 2023 Dec;
21:100201.
PMID: 38098883
The regrowth and subsequent exposure of opportunistic pathogens (OPs) whilst reopening buildings that have been locked down due to the stay-at-home restrictions to limit the spread of COVID-19, is a...
4.
Kasperbauer S, Thomson R
Clin Chest Med
. 2023 Oct;
44(4):xiii-xiv.
PMID: 37890923
No abstract available.
5.
Burke A, Carter R, Tolson C, Congdon J, Duplancic C, Bursle E, et al.
Int J Antimicrob Agents
. 2023 Jul;
62(4):106938.
PMID: 37517624
Objectives: Mycobacterium abscessus is an emerging infection in people living with lung diseases, including cystic fibrosis (CF) and bronchiectasis, and it has limited treatment options and low cure rates. The...
6.
Broadbent P, Thomson R, Kopasker D, McCartney G, Meier P, Richiardi M, et al.
Lancet Reg Health Eur
. 2023 Apr;
27:100585.
PMID: 37035237
The UK, and other high-income countries, are experiencing substantial increases in living costs. Several overlapping and intersecting economic crises threaten physical and mental health in the immediate and longer term....
7.
Mercaldo R, Marshall J, Cangelosi G, Donohue M, Falkinham 3rd J, Fierer N, et al.
Tuberculosis (Edinb)
. 2023 Jan;
139:102305.
PMID: 36706504
The National Institute of Allergy and Infectious Diseases organized a symposium in June 2022, to facilitate discussion of the environmental risks for nontuberculous mycobacteria exposure and disease. The expert researchers...
8.
Lee A, Smith R, Burr L, Chang A, Holmes-Liew C, King P, et al.
Clin Respir J
. 2022 Nov;
17(1):59-69.
PMID: 36404576
Introduction: Pulmonary rehabilitation is recommended for people with bronchiectasis. Various education topics are included in these programmes, but the content is largely guided by the needs of people with other...
9.
Kapur N, Stroil-Salama E, Morgan L, Yerkovich S, Holmes-Liew C, King P, et al.
Respir Med
. 2021 Sep;
188:106627.
PMID: 34592538
Introduction: In adults with bronchiectasis, multicentre data advanced the field including disease characterisation and derivation of phenotypes such as 'frequent exacerbator (FE)' (≥3 exacerbations/year). However, paediatric cohorts are largely limited...
10.
Ruis C, Bryant J, Bell S, Thomson R, Davidson R, Hasan N, et al.
Nat Microbiol
. 2021 Sep;
6(10):1279-1288.
PMID: 34545208
Mycobacterium abscessus, a multidrug-resistant nontuberculous mycobacterium, has emerged as a major pathogen affecting people with cystic fibrosis (CF). Although originally thought to be acquired independently from the environment, most individuals...